化合物T8913 T8913
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 260555-42-8 | ¥287.00 | 询底价 |
100 mg | 260555-42-8 | ¥1,650.00 | 询底价 |
200 mg | 260555-42-8 | ¥2,470.00 | 询底价 |
50 mg | 260555-42-8 | ¥1,090.00 | 询底价 |
25 mg | 260555-42-8 | ¥735.00 | 询底价 |
1 mg | 260555-42-8 | ¥142.00 | 询底价 |
10 mg | 260555-42-8 | ¥427.00 | 询底价 |
1 mL | 260555-42-8 | ¥249.00 | 询底价 |
Product Introduction
Bioactivity
英文名: 1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID
描述: 1-(2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID 靶向 GRK2。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 22.5 mg/mL (85.47 mM)
关键字: 1 (2,3 DIHYDRO BENZO[1,4]DIOXIN 6 YL) 5 OXO PYRROLIDINE 3 CARBOXYLIC ACID | 1(2,3DIHYDROBENZO[1,4]DIOXIN6YL)5OXOPYRROLIDINE3CARBOXYLIC ACID
相关产品: GSK299115A | GRK5-IN-2 | CCG258208 | CCG215022 | Takeda103A | GRK2-IN-1 hydrochloride (2055990-90-2 free base) | CMPD101 | GRK6-IN-2 | Paroxetine hydrochloride | GSK270822A
相关库: Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | GPCR Compound Library | Carboxylic Acid Fragment Library With Solubility | NO PAINS Compound Library | Bioactive Compound Library
化合物T8913 T8913信息由TargetMol中国为您提供,如您想了解更多关于化合物T8913 T8913报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途